264
Participants
Start Date
November 12, 2015
Primary Completion Date
October 21, 2021
Study Completion Date
October 21, 2021
HYQVIA
Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase
Columbia University Medical Center, New York
Montefiore Medical Center, The Bronx
Northwell Health, Inc. PRIME, Great Neck
Winthrop University, Mineola
Corning Center for Clinical Research, Corning
Allergy & Clinical Immunology Associates, Pittsburgh
Carolinas Healthcare System, Charlotte
Allergy Asthma & Immunology Relief of Charlotte, Charlotte
Georgia Pollens Clinical Research Centers, Inc., Albany
Optimed Research, LTD, Columbus
Washington University, St Louis
Allergy, Asthma and Clinical Research Center, Oklahoma City
OK Institute of Allergy & Asthma Clinical Research, LLC, Oklahoma City
Vital Prospects Clinical Research Institute, P.C., Tulsa
McKinney Allergy and Asthma Center, McKinney
Allergy / Immunology Research Center of North Texas, Dallas
Texas Children's Hospital, Houston
IMMUNOe International Research Centers, Thornton
Asthma and Allergy Associates, PC, Colorado Springs
Pikes Peak Allergy and Asthma, Colorado Springs
University of Utah, Salt Lake City
Riviera Allergy Medical Center, Redondo Beach
UCLA School of Medicine, Santa Monica
University of California Irvine Medical Center, Irvine
Kern Allergy Medical Clinic, Bakersfield
Capital Allergy & Respiratory Disease Center, Sacramento
Boston Childrens Hospital, Boston
Canton Health Center, Canton
National Allergy, Asthma & Urticaria Centers of Charleston, PA, North Charleston
Greater Austin Allergy, Asthma, & Immunology, Round Rock
Baxalta now part of Shire
INDUSTRY